22:34 GMT07 August 2020
Listen Live
    Get short URL
    0 85

    The company’s earnings fell about 15 percent as sales decreased to $5.2 billion in 2015 from $5.8 billion in 2014.

    WASHINGTON (Sputnik) — The leading producer of genetically engineered seeds and herbicides Monsanto reported lower earnings in the first half of 2015 caused by weaker sales, according to a press release issued by the company on Wednesday.

    “The company’s second quarter earnings per share was $2.90 on an ongoing basis and $2.92 on an as-reported basis,” the press release said. “For the first half of fiscal year 2015, cash flow from operations was a source of approximately $1.5 billion, compared to $1.8 billion the same period last year.”

    Monsanto second-quarter profit stood at $1.42 billion, compared to $1.67 billion, in the second quarter of 2014.

    The company’s earnings fell about 15 percent as sales decreased to $5.2 billion in 2015 from $5.8 billion in 2014.

    The industry-wide decline in corn plantings and a stronger US dollar influenced Monsanto’s performance, according to the press release.

    US-based Monsanto is one of the world’s largest agricultural companies, producing genetically engineered seeds as well as herbicides.

    A rally against biotech giant Monsanto in Washington, DC on  January 10, 2013.
    K. Zeitvogel
    A rally against biotech giant Monsanto in Washington, DC on January 10, 2013.

    In February 2015, the US environment watchdog Center for Food Safety issued a report saying that Monsanto’s signature herbicide Roundup Ready is leading to the decimation of Monarch butterfly populations.

    In 2013, multiple protests started against Monsanto in about 400 cities around the world. The protesters accused the biotechnology giant turning a blind eye to the potentially deadly effects of its genetically modified organisms in crops and food that it sells globally.

    Monsanto Generic
    Monsanto Generic



    FDA Approves GMO Apples, Potatoes But Companies Won’t Use Them
    GMO Mosquitoes May Have Unintended Consequences, Scientists Warn
    GMO Humans? Scientists Warn of Risks
    Monsanto Shareholders Overwhelmingly Oppose GMO Labeling
    sales decline, GMO, Monsanto, United States
    Community standardsDiscussion